Aromasin

Exemestane, commonly marketed as Aromasin, is an aromatase inhibitor used primarily in the treatment
of hormone-receptor-positive breast cancer in postmenopausal women. Aromatase is an enzyme
responsible for the conversion of androgens, specifically testosterone, into estrogen. By inhibiting
aromatase, exemestane reduces estrogen levels in the body, which is crucial in breast cancer treatment as
estrogen can stimulate the growth of certain types of breast tumors.